Zynerba Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
ZYNE Zynerba Pharmaceuticals Inc
IGC India Globalization Capital Inc
KSM DWS Strategic Municipal Income Trust
CNC Centene Corp
WPM Wheaton Precious Metals Corp
HPX^ HPX Corp
KRNLU Kernel Group Holdings Inc
$TFRRU1000GCADL Russell 1000 Growth CAD Total Return
AOUT American Outdoor Brands Inc
BDC Belden Inc
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Zynerba Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company. The Company is focused on the development of pharmaceutically produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, including Fragile X syndrome (FXS), autism spectrum disorder (ASD), 22q11.2 deletion syndrome (22q), and a heterogeneous group of rare epilepsies known as developmental and epileptic encephalopathies (DEE). Its lead product candidate, Zygel (ZYN002 CBD Gel) is a cannabidiol (CBD) gel for FXS, ASD in pediatric patients, 22q, and a heterogeneous group of rare epilepsies known as DEE. Its clinical program for Zygel includes clinical trials evaluating Zygel in the treatment of behavioral symptoms of FXS, ASD and 22q and the reduction of seizures and the treatment of associated symptoms in patients with DEE syndromes.

Price
Delayed
$3.27
Day's Change
-0.0416 (-1.26%)
Bid
--
Ask
--
B/A Size
--
Day's High
3.37
Day's Low
3.23
Volume
(Light)

Today's volume of 499,150 shares is on pace to be much lighter than ZYNE's 10-day average volume of 1,610,663 shares.

499,150
  • Prev Close
    3.31
  • Today's Open
    3.31
  • Day's Range
    3.23-3.37
  • Avg Vol (10-day)
    1.6M
  • Last (time)
    1:48p ET 12/02/21
  • Last (size)
    100
  • 52-Wk Range
    3.15 - 9.00
    LowHigh
  • (12/29/20 - 02/10/21)
    3.76%
  • 101.6%
  • Market Cap
    134.4M
  • Shares Outstanding
    41.2M
  • -1.04
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.3
  • 33.00
  • (% of float 11/15/21)
    5.96

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.